4//SEC Filing
Michael Robert A. 4
Accession 0001415889-24-006163
CIK 0001551152other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 5:50 PM ET
Size
16.0 KB
Accession
0001415889-24-006163
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Michael Robert A.
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Tax Payment
Common Stock, $0.01 par value
2024-02-28$178.99/sh−37,638$6,736,826→ 145,964 total - Exercise/Conversion
Common Stock, $0.01 par value
2024-02-29$61.36/sh+11,420$700,731→ 157,384 total - Sale
Common Stock, $0.01 par value
2024-02-29$176.46/sh−47,319$8,349,911→ 98,645 total - Exercise/Conversion
Common Stock, $0.01 par value
2024-02-29$54.86/sh+10,140$556,280→ 167,524 total - Sale
Common Stock, $0.01 par value
2024-02-29$176.44/sh−21,560$3,804,046→ 145,964 total - Exercise/Conversion
Option (Right to Buy)
2024-02-29$61.36/sh−11,420$700,731→ 0 totalExercise: $61.36From: 2018-02-16Exp: 2027-02-15→ Common Stock (11,420 underlying) - Exercise/Conversion
Option (Right to Buy)
2024-02-29$54.86/sh−10,140$556,280→ 0 totalExercise: $54.86From: 2017-02-18Exp: 2026-02-17→ Common Stock (10,140 underlying)
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.39 to $176.57, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.42 to $176.60, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
AbbVie Inc.
CIK 0001551152
Entity typeother
Related Parties
1- filerCIK 0001699914
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 5:50 PM ET
- Size
- 16.0 KB